Vascular calcification is associated with increased cardiovascular morbidity and mortality. A number of calcification inhibitors have been defined recently, including inorganic pyrophosphate (PPi), an important physicochemical inhibitor of hydroxyapatite crystal growth. Increased hydrolysis of PPi by tissue-nonspecific alkaline phosphatase (TNAP) may occur in renal failure and act to enhance mineralization of vessels
Pathogenesis of vascular calcification in chronic kidney disease.BackgroundHyperphosphatemia and hyp...
Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the ext...
Background Hyperphosphatemia and hypercalcemia are independent risk factors for higher incidence of ...
Pyrophosphate is a potent inhibitor of medial vascular calcification where its level is controlled b...
Patients with chronic kidney disease (CKD) suffer from arterial media calcification and a disturbed ...
Matrix vesicle (MV)-mediated mineralization is important for bone ossification. However, under certa...
Cardiovascular disease is the main cause of early death in the settings of chronic kidney disease (C...
International audienceCardiovascular calcification (CVC) is associated with increased morbidity and ...
International audienceCardiovascular calcification (CVC) is associated with increased morbidity and ...
Calcification and cardiovascular problems in renal failure. Extraosseus calcification has plagued ma...
Alkaline phosphatase (ALP) is an evolutionary conserved enzyme and widely used biomarker in clinical...
Vascular calcification is a pathology characterized by the deposition of calcium-phosphate in cardio...
Pathogenesis of vascular calcification in chronic kidney disease.BackgroundHyperphosphatemia and hyp...
Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the ext...
Background Hyperphosphatemia and hypercalcemia are independent risk factors for higher incidence of ...
Pyrophosphate is a potent inhibitor of medial vascular calcification where its level is controlled b...
Patients with chronic kidney disease (CKD) suffer from arterial media calcification and a disturbed ...
Matrix vesicle (MV)-mediated mineralization is important for bone ossification. However, under certa...
Cardiovascular disease is the main cause of early death in the settings of chronic kidney disease (C...
International audienceCardiovascular calcification (CVC) is associated with increased morbidity and ...
International audienceCardiovascular calcification (CVC) is associated with increased morbidity and ...
Calcification and cardiovascular problems in renal failure. Extraosseus calcification has plagued ma...
Alkaline phosphatase (ALP) is an evolutionary conserved enzyme and widely used biomarker in clinical...
Vascular calcification is a pathology characterized by the deposition of calcium-phosphate in cardio...
Pathogenesis of vascular calcification in chronic kidney disease.BackgroundHyperphosphatemia and hyp...
Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the ext...
Background Hyperphosphatemia and hypercalcemia are independent risk factors for higher incidence of ...